Have a feature idea you'd love to see implemented? Let us know!

NVS Novartis AG

Price (delayed)

$106.26

Market cap

$209.87B

P/E Ratio

17.95

Dividend/share

$7.52

EPS

$5.92

Enterprise value

$229.81B

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world ...

Highlights
The gross profit rose by 14% year-on-year and by 4% since the previous quarter
Novartis AG's revenue has increased by 11% YoY and by 3.6% QoQ
The stock's P/E is 27% more than its last 4 quarters average of 14.1 but 5% less than its 5-year quarterly average of 18.9
The company's debt rose by 19% YoY but it fell by 2.4% QoQ
The company's net income fell by 32% QoQ and by 20% YoY
The company's EPS fell by 31% QoQ and by 17% YoY

Key stats

What are the main financial stats of NVS
Market
Shares outstanding
1.98B
Market cap
$209.87B
Enterprise value
$229.81B
Valuations
Price to earnings (P/E)
17.95
Price to book (P/B)
4.82
Price to sales (P/S)
4.15
EV/EBIT
15.69
EV/EBITDA
9.24
EV/Sales
4.44
Earnings
Revenue
$51.72B
Gross profit
$38.9B
Operating income
$14.54B
Net income
$11.94B
EBIT
$14.65B
EBITDA
$24.88B
Free cash flow
$16.34B
Per share
EPS
$5.92
EPS diluted
$5.87
Free cash flow per share
$8.1
Book value per share
$22.03
Revenue per share
$25.63
TBVPS
$25.06
Balance sheet
Total assets
$102.25B
Total liabilities
$58.12B
Debt
$31.4B
Equity
$44.05B
Working capital
$1.01B
Liquidity
Debt to equity
0.71
Current ratio
1.04
Quick ratio
0.73
Net debt/EBITDA
0.8
Margins
EBITDA margin
48.1%
Gross margin
75.2%
Net margin
23.1%
Operating margin
28.1%
Efficiency
Return on assets
12%
Return on equity
28.3%
Return on invested capital
37.9%
Return on capital employed
19.9%
Return on sales
28.3%
Dividend
Dividend yield
7.07%
DPS
$7.52
Payout ratio
127%

NVS stock price

How has the Novartis AG stock price performed over time
Intraday
-0.67%
1 week
1.47%
1 month
7.36%
1 year
2.71%
YTD
9.2%
QTD
9.2%

Financial performance

How have Novartis AG's revenue and profit performed over time
Revenue
$51.72B
Gross profit
$38.9B
Operating income
$14.54B
Net income
$11.94B
Gross margin
75.2%
Net margin
23.1%
NVS's operating income is up by 49% year-on-year and by 7% since the previous quarter
The company's net margin fell by 34% QoQ and by 27% YoY
NVS's operating margin is up by 34% year-on-year and by 3.3% since the previous quarter
The company's net income fell by 32% QoQ and by 20% YoY

Growth

What is Novartis AG's growth rate over time

Valuation

What is Novartis AG stock price valuation
P/E
17.95
P/B
4.82
P/S
4.15
EV/EBIT
15.69
EV/EBITDA
9.24
EV/Sales
4.44
The company's EPS fell by 31% QoQ and by 17% YoY
The stock's P/E is 27% more than its last 4 quarters average of 14.1 but 5% less than its 5-year quarterly average of 18.9
NVS's P/B is 24% above its 5-year quarterly average of 3.9 but 3.6% below its last 4 quarters average of 5.0
The company's equity fell by 6% YoY
Novartis AG's revenue has increased by 11% YoY and by 3.6% QoQ
The P/S is 3.5% less than the 5-year quarterly average of 4.3 and 3.5% less than the last 4 quarters average of 4.3

Efficiency

How efficient is Novartis AG business performance
Novartis AG's ROA has decreased by 33% from the previous quarter and by 12% YoY
NVS's ROE is down by 31% QoQ and by 10% YoY
The ROIC has declined by 28% since the previous quarter and by 17% year-on-year
The company's return on sales fell by 28% QoQ and by 19% YoY

Dividends

What is NVS's dividend history
DPS
$7.52
Dividend yield
7.07%
Payout ratio
127%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Novartis AG financials performed over time
NVS's total assets is 76% greater than its total liabilities
The quick ratio is down by 11% year-on-year and by 6% since the previous quarter
Novartis AG's current ratio has decreased by 10% YoY and by 6% QoQ
The company's debt is 29% lower than its equity
The debt to equity has grown by 25% YoY but it has contracted by 4.1% from the previous quarter
The company's debt rose by 19% YoY but it fell by 2.4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.